Tuesday | 7 October, 2008
Australian Biotechnology News
Immunology feature: landlords, tenants and immune response
Mariapia Degli-Esposti’s team at Perth’s Lions Eye Institute is looking closely at why the immune system puts up a good fight against some viral infections but has problems with others.
Graeme O'Neill 04/12/2007 15:20:13

Additional Resources

Newsletter Subscription

Sign up for our Australian Life Scientist newsletters!
The latest, most important headlines from Australia and around the world.
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world.

When you're a parasitic lodger with no independent means of survival, it's bad form to kill the landlord. And it pays not to challenge your host or draw attention to yourself, so you can't be evicted.

Perth immunologist Dr Mariapia Degli-Esposti, of the Lions Eye Institute, spends her time trying to understand why the mammalian immune system efficiently deals with some viral infections, yet responds ineffectually to others.

Her model host is the mouse, and its persistent tenant is the herpes virus, Murine Cytomegalovirus (MCMV).

The virus manipulates cellular immune responses so that it is not eliminated, but rather is allowed to establish a life-long relationship with its host.

Degli Esposti will describe her team's latest findings at annual conference of the Australasian Society for Immunology in Sydney this week.

"We're trying to understand how the immune system responds to challenges and why it sometimes doesn't respond in the best way possible," she says.

Sometimes, the immune response is not efficient enough to clear persistent pathogens like MCMV, or overlooks malignancies that can then develop into tumours.

She believes the mouse MCMV model is an ideal system for understanding what happens during the course of a viral infection, how the immune system responds, and how the virus manipulates that system to evade detection and elimination.

"The findings from these studies will not only generate critical information about the development of improved anti-viral therapies, but will also provide essential insights into key cellular processes and check-points," she says.

Indeed, this is what Degli-Esposti finds the most exciting aspect of her research and the discoveries her team has made to date.

Forward sentries

In 2001, Degli Esposti and her colleagues showed that MCMV preferentially infects the immune system's forward sentries, dendritic cells (DCs). Dendritic cells detect pathogens and migrate to lymph nodes, where they are classically known to activate CD4 helper-inducer T cells, and CD8 cytotoxic T cells.

Following MCMV infection, dendritic cells become irreversibly paralysed, explaining why infected hosts become transiently, but severely, immunosuppressed and unable to respond to subsequent challenges, such as infections with other viruses and/or bacteria.

"When we confirmed that the virus did interfere with dendritic cell functions, we wondered what it meant for their ability to generate downstream responses," she says.

Instead of focusing exclusively on CD4 and CD8 T cells, Degli Esposti's team extended their investigation to natural killer (NK) cells. In a paper in Nature Immunology in 2003, they described how dendritic cells interact with NK cells in a reciprocal fashion.

NK cells are an important arm of innate immunity and can quickly detect and destroy infected or transformed cells through mechanisms such as the display of low levels of MHC class I antigens - an early indicator of viral infection. NK cells are critical to mounting an effective immune response before cytotoxic T cells become activated.

Activated NK cells can kill infected cells and can secrete cytokines that have anti-viral functions, as well as the ability to affect other cellular effectors.

They can also produce chemotactic factors that may help to recruit cytotoxic T cells that specialise in detecting and destroying infected cells that, by now, are beginning to display specific viral peptides complexed with MHC Class I molecules on their surface.

More about Alpha, DCS

Australian Life Scientist Member Login

 
Sponsored Links